Teva Pharmaceutical Industries Ltd (NYSE:TEVA)
| 10.01 Delayed Data As of Aug 04 |  +0.085 / +0.86%Today’s Change | 8.24 Today|||52-Week Range 13.30 | +3.68% Year-to-Date |
Latest TEVA News | Press Releases
| TEVA Q2 Earnings Beat Estimates, Revenues Miss, Stock Up Jul 29 / Zacks.com - Paid Partner Content | The Smartest Stocks Under $10 to Buy Right Now Jul 23 / MotleyFool.com - Paid Partner Content |
| Teva Pharmaceutical Industries (TEVA) Q2 2021 Earnings Call Transcript Jul 28 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 9.92 |
| Today’s open | 9.85 |
| Day’s range | 9.83 - 10.14 |
| Volume | 9,319,025 |
| Average volume (3 months) | 8,673,634 |
| Market cap | $10.6B |
Data as of 4:00pm ET, 08/04/2021
Growth & Valuation
| Earnings growth (last year) | -299.46% |
| Earnings growth (this year) | +1.00% |
| Earnings growth (next 5 years) | +3.65% |
| Revenue growth (last year) | -0.90% |
| P/E ratio | NM |
| Price/Sales | 0.63 |
| Price/Book | 1.05 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| BBIOBridgeBio Pharma Inc | -0.01 | -0.02% |
| ---- | ||
| IMMBImmunotech Laborator... | 0.00 | 0.00% |
| BGNEBeigene Ltd | +1.00 | +0.29% |
Data as of 3:59pm ET, 08/04/2021
Financials
| Next reporting date | November 4, 2021 |
| EPS forecast (this quarter) | $0.65 |
| Annual revenue (last year) | $16.8B |
| Annual profit (last year) | -$4.0B |
| Net profit margin | -23.95% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Generic |
No executives to display |
Corporate headquarters Petach Tikva, Hamerkaz |
Forecasts
